These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 21795477
21. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L. Oncogene; 2011 Aug 04; 30(31):3416-28. PubMed ID: 21399664 [Abstract] [Full Text] [Related]
22. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2. Wang X, Li GH. J Cell Physiol; 2018 Dec 04; 233(12):9447-9457. PubMed ID: 30136280 [Abstract] [Full Text] [Related]
23. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M. Oncogene; 2011 Aug 11; 30(32):3489-501. PubMed ID: 21383697 [Abstract] [Full Text] [Related]
24. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z. Oncogene; 2014 Oct 16; 33(42):5017-27. PubMed ID: 24141785 [Abstract] [Full Text] [Related]
25. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Das G, Shiras A, Shanmuganandam K, Shastry P. Mol Carcinog; 2011 Jun 16; 50(6):412-23. PubMed ID: 21557327 [Abstract] [Full Text] [Related]
26. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Int J Oncol; 2011 Nov 16; 39(5):1099-107. PubMed ID: 21701775 [Abstract] [Full Text] [Related]
27. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors. Iwase M, Yoshiba S, Uchid M, Takaoka S, Kurihara Y, Ito D, Hatori M, Shintani S. Int J Oncol; 2007 Nov 16; 31(5):1141-7. PubMed ID: 17912441 [Abstract] [Full Text] [Related]
28. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki KI, Amagasa T, Inazawa J. Oncogene; 2007 Dec 13; 26(57):7921-32. PubMed ID: 17599052 [Abstract] [Full Text] [Related]
29. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671 [Abstract] [Full Text] [Related]
30. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. Yoshitomi T, Kawakami K, Enokida H, Chiyomaru T, Kagara I, Tatarano S, Yoshino H, Arimura H, Nishiyama K, Seki N, Nakagawa M. Oncol Rep; 2011 Jun 01; 25(6):1661-8. PubMed ID: 21479368 [Abstract] [Full Text] [Related]
31. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro. Yang X, Wu H, Ling T. Mol Med Rep; 2014 Jul 01; 10(1):125-30. PubMed ID: 24789258 [Abstract] [Full Text] [Related]
32. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways. Fukumoto I, Hanazawa T, Kinoshita T, Kikkawa N, Koshizuka K, Goto Y, Nishikawa R, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N. Br J Cancer; 2015 Mar 03; 112(5):891-900. PubMed ID: 25668004 [Abstract] [Full Text] [Related]
33. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma. Du Y, Li Y, Lv H, Zhou S, Sun Z, Wang M. Int J Clin Exp Pathol; 2015 Mar 03; 8(10):12252-9. PubMed ID: 26722410 [Abstract] [Full Text] [Related]
34. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. Oral Oncol; 2010 Mar 03; 46(3):204-8. PubMed ID: 20138800 [Abstract] [Full Text] [Related]
35. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Wang J, Jiang C, Li N, Wang F, Xu Y, Shen Z, Yang L, Li Z, He C. Cell Death Dis; 2020 Aug 12; 11(8):682. PubMed ID: 32826876 [Abstract] [Full Text] [Related]
36. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA, Gutkind JS. Cancer Res; 2005 Nov 01; 65(21):9953-61. PubMed ID: 16267020 [Abstract] [Full Text] [Related]
37. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Xiong J, Du Q, Liang Z. Oncogene; 2010 Sep 02; 29(35):4980-8. PubMed ID: 20562918 [Abstract] [Full Text] [Related]
38. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C. Carcinogenesis; 2011 Aug 02; 32(8):1183-9. PubMed ID: 21665894 [Abstract] [Full Text] [Related]
39. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, Wu KJ, Chiou SH, Lin SC, Chang KW. Cancer Res; 2010 Feb 15; 70(4):1635-44. PubMed ID: 20145132 [Abstract] [Full Text] [Related]
40. MicroRNA-92b promotes tumor growth and activation of NF-κB signaling via regulation of NLK in oral squamous cell carcinoma. Liu Z, Diep C, Mao T, Huang L, Merrill R, Zhang Z, Peng Y. Oncol Rep; 2015 Dec 15; 34(6):2961-8. PubMed ID: 26503628 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]